in change was found between the intervention and control group, while in Dutch patients with diabetes 33 there was a significantly higher reduction in glucose concentrations after one year of intervention, in favour of the control group. In newly diagnosed diabetes patients, 41 the intervention group was observed to have a significantly higher reduction in fasting glucose levels then the control group after six years of intervention. Creatinine levels were assessed in three 33 41 46 out of the seven trials. Only the pooled five-year results from Addition-Europe 46 showed a significant difference in change between the trial arms, favouring the control arm over the intervention arm (see supplementary figure S8 ).
Further diabetes complications and related outcomes
Episodes of severe hypoglycaemia were assessed in only one 44 of the three studies with prevalent diabetes patients, in which severe hypoglycaemia was defined as having one or more episodes of hypoglycaemia with clinical symptoms and or requiring hospitalization. Episodes were reported for 19 (11.6%) patients in the intervention group and for eight (5.1%) in the control This was also observed after pooling of the five-year findings from the Addition studies. 46 In 2 newly diagnosed diabetes patients 41 however, the only between-group difference that was observed with regard to medication intake was the more extensive use of metformin in the intervention group (39 (9%)) compared to the control group (16 (4%)).
